Cognitive decline and dementia in the elderly hypertensive

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 3, Issue SUPPL. 1, 2002, Pages

  Hanon, Olivier ^a   Leys, Didier ^a  

^a Paris Descartes University   (France)

Author keywords

Cognitive decline; Dementia; Hypertension

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN HEXETIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; OMAPATRILAT;

ADULT; AGED; BLOOD PRESSURE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DRUG EFFECT; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; PATHOGENESIS; REVIEW; RISK FACTOR;

EID: 0036756659     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2002.028     Document Type: Review

References (71)

1. Snowdon DA, Greiner LH, Mortimer JA et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997;277:813-17.
2. Victoroff J, Mack WJ, Lyness SA, Chui HC. Multicenter clinicopathological correlation in dementia. Am J Psychiatry 1995;152:1476-84.
3. Jellinger K, Danielczyk W, Fischer P, Gabriel E. Clinicopathological analysis of dementia disorders in the elderly. J Neurol Sci 1990;5:239-58.
4. Hofman A, Ott A, Breteler MM et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997;349:151-4.
5. Kilander L. Cognitive dysfunction in the elderly. The implication of cerebrovascular risk factors. Acta Universitatis Upsaliensis 1997. Uppsala University Library, Uppsala, Sweden.
6. Kuusisto J, Koivisto K, Mykkanen L et al. Essential hypertension and cognitive function. The role of hyperinsulinemia. Hypertension 1993;22:771-9.
7. Starr JM, Whalley LJ, Inch S, Shering PA. Blood pressure and cognitive function in healthy old people. J Am Geriatr Soc 1993;41:753-6.
8. Seux ML, Thijs L, Forette F et al. Correlates of cognitive status of old patients with isolated systolic hypertension: the Syst-Eur Vascular Dementia Project. J Hypertens 1998;16:963-9.
9. Wallace RB, Lemke JH, Morris MC et al. Relationship of free-recall memory to hypertension in the elderly. The Iowa 65+ Rural Health Study. J Chronic Dis 1985;38:475-81.
10. Cacciatore F, Abete P, Ferrara N et al. The role of blood pressure in cognitive impairment in an elderly population. Osservatorio Geriatrico Campano Group. J Hypertens 1997;15:135-42.
11. Gale CR, Martyn CN, Cooper C. Cognitive impairment and mortality in a cohort of elderly people. BMJ 1996;312:608-11.
12. Farmer ME, White LR, Abbott RD et al. Blood pressure and cognitive performance; The Framingham study. Am J Epidemiol 1987;126:1103-14.
13. Scherr PA, Hebert LE, Smith LA, Evans DA. Relation of blood pressure to cognitive functions in the elderly. Am J Epidemiol 1991;134:1303-15.
14. Desmond DW, Tatemichi TK, Paik M, Stern Y. Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort. Arch Neurol 1993;50:162-6.
15. van Boxtel MPJ, Gaillard C, Houx PJ, Buntinx F, de Leeuw PW, Jolles J. Can the blood pressure predict task performance in a healthy population sample? J Hypertens 1997;15:1069-76.
16. Guo Z, Viitanen M, Fratiglioni L, Winblad B. Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ 1996;312:805-8.
17. Wilkie F, Eisdorfer C. Intelligence and blood pressure in the aged. Science 1971;172:959-62.
18. Elias ME, Wolf PA, d'Agostino RB, Cobb J, White LR. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol 1993;138:353-64.
19. Elias PK, d'Agostino RB, Elias MF, Wolf PA. Blood pressure, hypertension, and age as risk factors for poor cognitive performance. Exp Aging Res 1995;21:393-417.
20. Launer J, Masaki K, Petrovitch H, Foley D, Havlik RJ. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA 1995;274:1846-51.
21. Kilander L, Nyman H, Boberg M, Hansson L, Lithell H. Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension 1998;31:780-6.
22. Starr JM, Deary IJ, Inch S, Cross S, MacLennan WJ. Blood pressure and cognitive decline in healthy old people. J Hum Hypertens 1997;11:777-81.
23. Tzourio C, Dufouil C, Ducimetière P et al. Cognitive decline in individuals with high blood pressure. Neurology 1999;53:1948-52.
24. Knopman D, Boland LL, Mosley T et al. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001;56:42-8.
25. Okumiya K, Matsubayashi K, Wada T et al. J-curve relation between blood pressure and decline in cognitive function in older people living in community, Japan. J Am Geriatr Soc 1997;45:1032-3.
26. Zhu L, Viitanen M, Guo Z, Winblad B, Fratiglioni L. Blood pressure reduction, cardiovascular diseases and cognitive decline in the Mini-Mental State Examination in a community population of normal very old people: a three-year follow-up. J Clin Epidemiol 1998;51:385-91.
27. Glynn RJ, Beckett LA, Hebert LE et al. Current and remote blood pressure and cognitive decline. JAMA 1999;281:438-45.
28. Cacciatore F, Abete P, Ferrara N et al. Congestive heart failure and cognitive impairment in an older population. J Am Geriatr Soc 1998;46:1343-8.
29. Ott A, Stolk RP, van Harskamp F et al. Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 1999 10;53:1937-42.
30. Kuusisto J, Koivisto K, Mykkanen L et al. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study. BMJ 1997;315:1045-9.
31. Kivipelto M, Helkala EL, Laakso MP et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 2001;322:1447-51.
32. Skoog I, Lernfelt B, Landahl S et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996;347:1141-5.
33. Launer LJ, Ross GW, Petrovitch H et al. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging 2000 Jan-Feb;21:49-55.
34. Heckbert SR, Longstreth WT, Psaty BM et al. The association of antihypertensive agents with MRI white matter findings and with modified Mini-Mental State Examination in older adults. J Am Geriatr Soc 1997;45:1423-33.
35. Maxwell CJ, Hogan DB, Ebly EM. Calcium-channel blockers and cognitive function in elderly people: results from the Canadian Study of Health and Aging. CMAJ 1999;161:501-06.
36. Meyer JS, Judd BW, Tawaklna T, Rogers RL, Mortel KF. Improved cognition after control of risk factors for multi-infarct dementia. JAMA 1986;256:2203-09.
37. Guo Z, Fratiglioni L, Zhu L et al. Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. Arch Neurol 1999;56:991-6.
38. Starr JM, Whalley LJ, Deary IJ. The effects of antihypertensive treatment on cognitive function: results from the HOPE study. J Am Geriatr Soc 1996;44:411-15.
39. Prince MJ, Bird AS, Blizard RA, Mann AH. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults. BMJ 1996;312:801-05.
40. Applegate WB, Pressels S, Wittes J et al. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the Systolic Hypertension in the Elderly Program. Arch Intern Med 1994;154:2154-60.
41. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64.
42. Di Bari M, Pahor M, Franse LV et al. Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial. Am J Epidemiol 2001;153:72-8.
43. Forette F, Seux M-L, Staessen JA et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998;352:1347-51.
44. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. PROGRESS Collaborative Group. Lancet 2001;358:1033-41.
45. Hansson L, Lithell H, Skoog I, Baro F, Banki CM, Breteler M et al. Study on Cognition and Prognosis in the Elderly (SCOPE). Blood Press 1999;8:177-83.
46. Folstein MF, Folstein SE, Mc Hugh PR. Mini Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
47. Hansson L, Lithell H, Skoog I et al. Study on COgnition and Prognosis in the Elderly (SCOPE): baseline characteristics. Blood Press 2000;9:146-51.
48. Kostis JB, Cobbe S, Johnston C et al. OPERA Study Group. Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events. Design of the Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events (OPERA) trial. Am J Hypertens 2002;15:193-8.
49. Bulpitt C, Fletcher A, Beckett N et al. Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial. Drugs Aging 2001;18:151-64.
50. Parnetti L, Senin U, Mecocci P. Cognitive enhancement therapy for Alzheimer's disease. The way forward. Drugs 1997;53:752-68.
51. Strandgaard S, Paulson OB. Cerebrovascular consequences of hypertension. Lancet 1994;344:519-20.
52. Tatemichi TK, Foulkes MA, Mohr JP et al. Dementia in stroke survivors in the Stroke Data Bank cohort. Prevalence, incidence, risk factors, and computed tomographic findings. Stroke 1990;21:858-66.
53. Tatemichi TK, Paik M, Bagiella E et al. Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology 1994;44:1885-91.
54. Kokmen E, Whisnant JP, O'Fallon WM, Chu CP, Beard CM. Dementia after ischemic stroke. A population based study in Rochester, Minnesota (1960-1984). Neurology 1996;46:154-9.
55. Henon H, Pasquier F, Durieu I et al. Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome. Stroke 1997;28:2429-36.
56. Pasquier F, Leys D. Why are stroke patients prone to develop dementia? J Neurol 1997;244:135-42.
57. Longstreth WT Jr, Manolio TA, Arnold A et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996;27:1274-82.
58. Leys D, Soetaert G, Petit H et al. Periventricular and white matter magnetic resonance imaging hyperintensities do not differ between Alzheimer's disease and normal aging. Arch Neurol 1990;47:524-7.
59. Breteler MMB, van Swieten JC, Bots ML et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam study. Neurology 1994;44:1246-52.
60. Rezek DL, Morris JC, Fulling KH, Gado MH. Periventricular white matter lucencies in senile dementia of the Alzheimer type and in normal aging. Neurology 1987;37:1365-8.
61. Arregui A, Perry EK, Rossor M, Tomlinson BE. Angiotensin converting enzyme in Alzheimer's disease increased activity in caudate nucleus and cortical areas. J Neurochem 1982;38:1490-2.
62. Wright JW, Harding JW. Brain angiotensin receptor subtypes in the control of physiological and behavioral responses. Neurosci Biobehav Rev 1994;18:21-53.
63. Barnes NM, Champaneria S, Costall B et al. Cognitive enhancing actions of DuP 753 detected in a mouse habituation paradigm. Neuroreport 1990;1:239-42.
64. Swan GE, Carmelli D, Larue A. Systolic blood pressure tracking over 25 to 30 years and cognitive performance in older adults. Stroke 1998;29:2334-40.
65. Guo Z, Fratiglioni L, Winblad B, Viitanen M. Blood pressure and performance on the Mini-Mental State Examination in the very old. Am J Epidemiol 1997;145:1106-13.
66. Kokmen E, Beard CM, Chandra V et al. Clinical risk factors for Alzheimer's disease: a population-based case-control study. Neurology 1991;41:1393-7.
67. Prince M, Cullen M, Mann A. Risk factors for Alzheimer's disease and dementia: a case-control study based on the MRC elderly hypertension trial. Neurology 1994;44:97-104.
68. Sparks DL, Scheff SW, Liu H et al. Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension. J Neurol Sci 1995;131:162-9.
69. Yoshitake T, Kiyohara Y, Kato I et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 1995;45:1161-8.
70. Landin K, Blennow K, Wallin A, Gottfries CG. Low blood pressure and blood glucose levels in Alzheimer's disease. Evidence for a hypometabolic disorder? J Intern Med 1993;233:357-63.
71. Guo Z, Viitanen M, Winblad B, Fratiglioni L. Low blood pressure and incidence of dementia in a very old sample: dependent on initial cognition. J Am Geriatr Soc 1999;47:723-6.